World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
52061
World Ranking
3620
National Ranking
99

Overview

Stanislas Pol is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, with a particular focus on hepatology and epidemiology. Their research covers a range of topics related to liver diseases, viral hepatitis, and hepatocellular carcinoma.

The main fields of study for this scientist include:

  • Medicine

Within medicine, their subfields of study are:

  • Epidemiology
  • Hepatology
  • Oncology
  • Immunology
  • Infectious Diseases

The primary research topics addressed by Stanislas Pol span:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Alcohol Consumption and Health Effects
  • Hepatitis Viruses Studies and Epidemiology

Recent notable publications include:

  • "High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold" (2023), published in Diabetes Care
  • "Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis" (2021), published in Gut
  • "Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status" (2020), published in Journal of Hepatology
  • "Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area" (2020), published in JHEP Reports
  • "Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020" (2021), published in Journal of Hepatology

Frequent co-authors collaborating with Stanislas Pol include:

  • Fabrice Carrat
  • Victor de Lédinghen
  • Fabien Zoulim
  • Nathalie Ganne-Carrié
  • Marc Bourlière

The most common venues for their publications are:

  • Journal of Hepatology
  • JHEP Reports
  • Liver International
  • Alimentary Pharmacology & Therapeutics
  • SSRN Electronic Journal

Best Publications

  • FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.

    Anaïs Vallet-Pichard;Anaïs Vallet-Pichard;Vincent Mallet;Vincent Mallet;Bertrand Nalpas;Bertrand Nalpas;Virginie Verkarre

  • Telaprevir for retreatment of HCV infection.

    Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz

  • Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

    Christophe Hézode;Nicole Forestier;Geoffrey Dusheiko;Peter Ferenci

  • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

  • Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

    P. André;F. Komurian-Pradel;S. Deforges;M. Perret

  • Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

    David Roth;David R. Nelson;Annette Bruchfeld;Annmarie Liapakis

  • Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

    Christian Bréchot;Valérie Thiers;Dina Kremsdorf;Bertrand Nalpas

  • Hepatitis C Virus Type 1b (II) Infection in France and Italy

    Jean-Baptiste Nousbaum;Stanislas Pol;Bertrand Nalpas;Paul Landais

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

    Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi

  • Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

    Pierre Nahon;Pierre Nahon;Valérie Bourcier;Richard Layese;Etienne Audureau

  • Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients

    Nassim Kamar;Jacques Izopet;Simona Tripon;Michael Bismuth

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

    Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

  • Noninvasive In Vivo Liver Fibrosis Evaluation Using Supersonic Shear Imaging: A Clinical Study on 113 Hepatitis C Virus Patients

    Éric Bavu;Éric Bavu;Jean-Luc Gennisson;Mathieu Couade;Jeremy Bercoff

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel

  • Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.

    Eva Herrmann;Victor de Lédinghen;Christophe Cassinotto;Winnie C.-W. Chu

  • All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

    Michael Peter Manns;Stanislas B Pol;Ira M Jacobson;Patrick M Marcellin

  • Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

    Edward Gane;Eric Lawitz;David Pugatch;Georgios Papatheodoridis

  • Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients

    Fabrice Carrat;Firouzé Bani-Sadr;Stanislas Pol;Eric Rosenthal

Frequent Co-Authors

Fabrice Carrat
Fabrice Carrat Sorbonne University
Patrice Cacoub
Patrice Cacoub Sorbonne University
Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Christophe Hézode
Christophe Hézode Université Paris Cité
Dominique Larrey
Dominique Larrey University of Montpellier
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées
Christian Bréchot
Christian Bréchot Institut Pasteur
Albert Tran
Albert Tran Inserm : Institut national de la santé et de la recherche médicale

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can offer flexibility and affordability for students considering a healthcare career in the U.S. One popular direction is psychiatric mental health nursing. For those seeking a quick entry or advancement in this field, the shortest pmhnp program options allow licensed nurses to become psychiatric nurse practitioners faster than traditional paths.

Interested in healthcare leadership or administration? An online health management degree can be a stepping stone toward roles in hospitals, clinics, or public health organizations. For those looking to further maximize value, there are several most affordable online mha programs that combine quality education with lower tuition costs.

If advancing clinical expertise is your goal, the cheapest online dnp programs can help you achieve a Doctor of Nursing Practice degree without the financial burden often associated with advanced degrees. Each pathway offers unique career prospects, greater earning potential, and the convenience of studying from anywhere.

Best Scientists Citing Stanislas Pol

Trending Scientists

Recently Published Articles